Table 5 Joinpoint regression analysis of age-standardized mortality rates in 45–64 year-old Lithuanian men and women, 1985–2013
Men | Women | ||||||||
|---|---|---|---|---|---|---|---|---|---|
Joinpoints (Years) | Time period | APC | 95 % CI | p-value | Joinpoints (Years) | Time period | APC | 95 % CI | p-value |
All-cause mortality | |||||||||
1995 | 1985–1995 | +4.4 | +3.0–+5.8 | <0.001 | 1995 | 1985–1995 | +2.3 | +1.2–+3.4 | <0.001 |
1999 | 1996–1999 | −6.3 | −13.9–+2.0 | 0.123 | 2000 | 1996–2000 | −4.7 | −8.9– −0.2 | 0.040 |
2007 | 2000–2007 | +2.7 | +0.4–+5.1 | 0.022 | 2007 | 2001–2007 | +2.4 | −0.1–+4.9 | 0.055 |
2008–2013 | −4.9 | −7.6– −2.2 | 0.001 | 2008–2013 | −4.6 | −6.9– −2.3 | 0.001 | ||
CVD mortality | |||||||||
1994 | 1985–1994 | +4.2 | +2.7–+5.8 | <0.001 | 1995 | 1985–1995 | +1.9 | +0.6–+3.2 | 0.005 |
1998 | 1995–1998 | −7.6 | −14.9–+0.2 | 0.056 | 2000 | 1996–2000 | −7.6 | −12.3– −2.7 | 0.005 |
2007 | 1999–2007 | +2.7 | +0.9–+4.5 | 0.006 | 2006 | 2001–2006 | +3.4 | −0.3–+7.2 | 0.071 |
2008–2013 | −5.0 | −7.6– −2.4 | 0.001 | 2007–2013 | −5.3 | −7.4– −3.3 | <0.001 | ||
CHD mortality | |||||||||
1994 | 1985–1994 | +4.3 | +2.9–+5.8 | <0.001 | 1995 | 1985–1995 | +3.1 | +1.6–+4.7 | 0.001 |
1998 | 1995–1998 | −11.1 | −17.6– −4.0 | 0.005 | 1999 | 1996–1999 | −15.2 | −23.1– −6.4 | 0.002 |
2006 | 1999–2006 | +2.3 | +0.5–+4.0 | 0.01 | 2006 | 2000–2006 | +4.4 | +1.0–+7.9 | 0.014 |
2007–2013 | −4.0 | −5.9– −2.0 | 0.001 | 2007–2013 | −4.9 | −7.4– −2.4 | 0.001 | ||
Mortality from malignant neoplasms | |||||||||
1993 | 1985–1993 | +2.1 | +1.3–+2.8 | <0.001 | 1994 | 1985–1994 | +0.5 | −0.5–+1.6 | 0.313 |
2002 | 1993–2002 | −1.8 | −2.5– −1.0 | <0.001 | 1995–2013 | −0.9 | −1.2– −0.5 | <0.001 | |
2007 | 2003–2007 | +0.7 | −1.5–+2.9 | 0.513 | |||||
2008–2013 | −2.9 | −4.0– −1.8 | <0.001 | ||||||